492 related articles for article (PubMed ID: 26838793)
21. Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy.
Luger D; Lipinski MJ; Westman PC; Glover DK; Dimastromatteo J; Frias JC; Albelda MT; Sikora S; Kharazi A; Vertelov G; Waksman R; Epstein SE
Circ Res; 2017 May; 120(10):1598-1613. PubMed ID: 28232595
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stem cells pretreated with delivered Hph-1-Hsp70 protein are protected from hypoxia-mediated cell death and rescue heart functions from myocardial injury.
Chang W; Song BW; Lim S; Song H; Shim CY; Cha MJ; Ahn DH; Jung YG; Lee DH; Chung JH; Choi KD; Lee SK; Chung N; Lee SK; Jang Y; Hwang KC
Stem Cells; 2009 Sep; 27(9):2283-92. PubMed ID: 19544472
[TBL] [Abstract][Full Text] [Related]
23. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
[TBL] [Abstract][Full Text] [Related]
24. Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells.
Chacko SM; Ahmed S; Selvendiran K; Kuppusamy ML; Khan M; Kuppusamy P
Am J Physiol Cell Physiol; 2010 Dec; 299(6):C1562-70. PubMed ID: 20861473
[TBL] [Abstract][Full Text] [Related]
25. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement.
Gnecchi M; He H; Noiseux N; Liang OD; Zhang L; Morello F; Mu H; Melo LG; Pratt RE; Ingwall JS; Dzau VJ
FASEB J; 2006 Apr; 20(6):661-9. PubMed ID: 16581974
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction.
Huang F; Li ML; Fang ZF; Hu XQ; Liu QM; Liu ZJ; Tang L; Zhao YS; Zhou SH
Cardiology; 2013; 125(1):18-30. PubMed ID: 23615185
[TBL] [Abstract][Full Text] [Related]
27. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model.
Lim SY; Kim YS; Ahn Y; Jeong MH; Hong MH; Joo SY; Nam KI; Cho JG; Kang PM; Park JC
Cardiovasc Res; 2006 Jun; 70(3):530-42. PubMed ID: 16563361
[TBL] [Abstract][Full Text] [Related]
28. Lack of Remuscularization Following Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells in Infarcted Nonhuman Primates.
Zhu K; Wu Q; Ni C; Zhang P; Zhong Z; Wu Y; Wang Y; Xu Y; Kong M; Cheng H; Tao Z; Yang Q; Liang H; Jiang Y; Li Q; Zhao J; Huang J; Zhang F; Chen Q; Li Y; Chen J; Zhu W; Yu H; Zhang J; Yang HT; Hu X; Wang J
Circ Res; 2018 Mar; 122(7):958-969. PubMed ID: 29343525
[TBL] [Abstract][Full Text] [Related]
29. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment.
Han XJ; Li H; Liu CB; Luo ZR; Wang QL; Mou FF; Guo HD
Life Sci; 2019 Sep; 233():116740. PubMed ID: 31398416
[TBL] [Abstract][Full Text] [Related]
30. Comparing the effects of MSCs and CD34+ cell therapy in a rat model of myocardial infarction.
Shalaby SM; El-Shal AS; Zidan HE; Mazen NF; Abd El-Haleem MR; Abd El Motteleb DM
IUBMB Life; 2016 May; 68(5):343-54. PubMed ID: 26949188
[TBL] [Abstract][Full Text] [Related]
31. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function.
Li W; Ma N; Ong LL; Nesselmann C; Klopsch C; Ladilov Y; Furlani D; Piechaczek C; Moebius JM; Lützow K; Lendlein A; Stamm C; Li RK; Steinhoff G
Stem Cells; 2007 Aug; 25(8):2118-27. PubMed ID: 17478584
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression.
Wisel S; Khan M; Kuppusamy ML; Mohan IK; Chacko SM; Rivera BK; Sun BC; Hideg K; Kuppusamy P
J Pharmacol Exp Ther; 2009 May; 329(2):543-50. PubMed ID: 19218529
[TBL] [Abstract][Full Text] [Related]
33. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J
Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354
[TBL] [Abstract][Full Text] [Related]
34. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.
Wei N; Yu SP; Gu X; Taylor TM; Song D; Liu XF; Wei L
Cell Transplant; 2013; 22(6):977-91. PubMed ID: 23031629
[TBL] [Abstract][Full Text] [Related]
35. Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model.
Shi B; Long X; Zhao R; Liu Z; Wang D; Xu G
Exp Biol Med (Maywood); 2014 Mar; 239(3):356-65. PubMed ID: 24477823
[TBL] [Abstract][Full Text] [Related]
36. Mechanical and Chemical Predifferentiation of Mesenchymal Stem Cells Into Cardiomyocytes and Their Effectiveness on Acute Myocardial Infarction.
Abd Emami B; Mahmoudi E; Shokrgozar MA; Dehghan MM; Farzad Mohajeri S; Haghighipour N; Marjanmehr SH; Molazem M; Amin S; Gholami H
Artif Organs; 2018 Jun; 42(6):E114-E126. PubMed ID: 29508429
[TBL] [Abstract][Full Text] [Related]
37. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction.
Tang YL; Zhao Q; Qin X; Shen L; Cheng L; Ge J; Phillips MI
Ann Thorac Surg; 2005 Jul; 80(1):229-36; discussion 236-7. PubMed ID: 15975372
[TBL] [Abstract][Full Text] [Related]
38. The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction.
Nassiri SM; Khaki Z; Soleimani M; Ahmadi SH; Jahanzad I; Rabbani S; Sahebjam M; Ardalan FA; Fathollahi MS
J Biomed Sci; 2007 Nov; 14(6):745-55. PubMed ID: 17605008
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
[TBL] [Abstract][Full Text] [Related]
40. Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms.
Santos Nascimento D; Mosqueira D; Sousa LM; Teixeira M; Filipe M; Resende TP; Araújo AF; Valente M; Almeida J; Martins JP; Santos JM; Bárcia RN; Cruz P; Cruz H; Pinto-do-Ó P
Stem Cell Res Ther; 2014 Jan; 5(1):5. PubMed ID: 24411922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
